Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea · Delayed Price · Currency is KRW 2,655.00
-80.00 (-2.93%)
At close: May 20, 2026
Vivozon Pharmaceutical Market Cap
Vivozon Pharmaceutical has a market cap or net worth of 159.74 billion as of May 21, 2026. Its market cap has decreased by -53.45% in one year.
Market Cap
159.74B
Enterprise Value
196.92B
Revenue
59.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,655.00
Market Cap Chart
Since November 18, 2005, Vivozon Pharmaceutical's market cap has increased from 72.45B to 159.74B, an increase of 120.48%. That is a compound annual growth rate of 3.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 159.74B | -20.40% |
| Dec 30, 2025 | 200.68B | -40.93% |
| Dec 30, 2024 | 339.73B | 134.89% |
| Dec 28, 2023 | 144.64B | -2.99% |
| Dec 29, 2022 | 149.09B | -19.87% |
| Dec 30, 2021 | 186.05B | -37.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synergy Innovation | 164.76B |
| KG Financial | 164.57B |
| CORESTEMCHEMON | 164.13B |
| Daihan Pharmaceutical | 163.76B |
| Dongbang Medical | 163.70B |
| T3 Entertainment | 163.25B |
| LS THiRA-UTECH | 163.19B |
| Korea Computer & Systems | 163.06B |